Skip to content

Azenta AZTA Multiomics — Total Cost of Revenue

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Cost Of Revenue
$109M-6.8%
nLIGHT, Inc. logo
LASRProducts — Total Cost of Revenue
$32.81M+38.3%
United Therapeutics logo
UTHRTotal Cost of Revenue
$133.4M+44.2%
Symbotic Inc. logo
SYMSystems — Total Cost of Revenue
$495.55M+19.5%
Moderna logo
MRNATotal Cost of Revenue
$955M+961%
Vertex Pharmaceuticals logo
VRTXTotal Cost of Revenue
$392.8M+8.2%

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-19.0%
Enterprise value$1.03B
P/S1.8×-0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's multiomics — total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's multiomics — total cost of revenue?
Azenta (AZTA) reported multiomics — total cost of revenue of $38.07M in Q1 2026.
How has Azenta's multiomics — total cost of revenue changed year-over-year?
Azenta's multiomics — total cost of revenue increased by 5.7% year-over-year, from $36.03M to $38.07M.
What does multiomics — total cost of revenue mean?
The direct costs associated with producing the goods and delivering the services sold by the Multiomics segment. This includes raw materials, direct labor, and overhead directly attributable to the segment's production processes. Analyzing this metric relative to revenue helps determine the gross margin efficiency of the segment's operations.